期刊
SCHIZOPHRENIA
卷 8, 期 1, 页码 -出版社
NATURE PORTFOLIO
DOI: 10.1038/s41537-021-00192-x
关键词
-
类别
资金
- Janssen Scientific Affairs
Clinical practice guidelines translate evidence into recommendations for improving patient care and outcomes. This review summarizes the recommendations for acute and maintenance management of schizophrenia with antipsychotics based on a systematic literature review of English-language guidelines. The guidelines recommend antipsychotic monotherapy for first-episode schizophrenia, but no consensus on the preferred antipsychotic. There is also variation in recommendations for the maximum duration of maintenance therapy and the use of long-acting injectable antipsychotics. Clozapine is recommended for treatment-resistant schizophrenia.
Clinical practice guidelines (CPGs) translate evidence into recommendations to improve patient care and outcomes. To provide an overview of schizophrenia CPGs, we conducted a systematic literature review of English-language CPGs and synthesized current recommendations for the acute and maintenance management with antipsychotics. Searches for schizophrenia CPGs were conducted in MEDLINE/Embase from 1/1/2004-12/19/2019 and in guideline websites until 06/01/2020. Of 19 CPGs, 17 (89.5%) commented on first-episode schizophrenia (FES), with all recommending antipsychotic monotherapy, but without agreement on preferred antipsychotic. Of 18 CPGs commenting on maintenance therapy, 10 (55.6%) made no recommendations on the appropriate maximum duration of maintenance therapy, noting instead individualization of care. Eighteen (94.7%) CPGs commented on long-acting injectable antipsychotics (LAIs), mainly in cases of nonadherence (77.8%), maintenance care (72.2%), or patient preference (66.7%), with 5 (27.8%) CPGs recommending LAIs for FES. For treatment-resistant schizophrenia, 15/15 CPGs recommended clozapine. Only 7/19 (38.8%) CPGs included a treatment algorithm.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据